Study ID: TVP - 1012/135 Open Label
Study Title
- Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients
Teva Identifier
- TVP - 1012/135 Open Label
ClinicalTrials.gov Identifier
- NCT00203164
Study Status
- Completed
Trial Condition(s)
- Parkinson's Disease
Interventions
- Drug: rasagiline mesylate
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 30 Years and older
Trial Duration
- 05/01/2002 - 09/01/2006
Phase
- Phase 3
Study Type
Interventional